Kevin Hern wants to be Oklahoma's next senator. Donald Trump said so on social media, in the kind of capital-letters endorsement that now functions as the Republican primary ballot in a state where Trump carried all 77 counties three elections running. The race is real, the June 24 primary is close, and Hern is the frontrunner. What's also real: the Ways and Means Republican has been quietly unloading a broad swath of his disclosed portfolio while keeping his hands on two energy names. Sixteen trades in 90 days will do that.
The Endorsement, Then the Portfolio
The social media announcement landed this week. Trump called Hern a "Great Patriot" and a "FANTASTIC Congressman" and a "true friend of MAGA" in the kind of post that reads like a press release written by someone who types in all caps for emphasis. Oklahoma Republicans will vote June 24 in what is otherwise an open primary for the seat being vacated by Jim Lankford.
Hern's campaign is running on the standard MAGA checklist: military, elections, the Second Amendment. The endorsement probably closes the race. What it doesn't close is the question of what Hern has been doing with his brokerage account while all this was in motion.
His full disclosure record at Blind Trust shows 16 trades filed in the last 90 days. The pattern has a shape to it.
Thirteen Sales, Two Energy Exchanges, One Very Large Goldman Exit
Walk through the tape.
On March 17 alone, Hern filed sales in six different positions: Cognizant Technology Solutions, Invesco, BlackRock Municipal Income Trust II, Invesco Ltd again (under IVZ), Kenvue, and Becton Dickinson. The range on each: 5,000 to $50,000 per position. That's a single day of clearing out across financials, consumer health, and medical devices.
March 18: a Texas Instruments sale in the $500,000 to ,000,000 range. That's the single largest transaction in the 90-day window by a wide margin.
March 20: four more sales. Prologis ($50K-00K), Medtronic (5K-$50K), T. Rowe Price (5K-$50K), and a position listed as PLCMDT (5K-$50K).
March 24: Exact Sciences goes, in the ,000 to 5,000 range.
April 29: Goldman Sachs, $250,000 to $500,000. Gone.
That's thirteen sales spread across semiconductors, financial services, logistics real estate, medical devices, diagnostics, and asset management. The direction is consistently out.
Then, on May 8, two exchanges: Devon Energy and Coterra Energy, 5,000 to $50,000 each. Exchanges (as opposed to purchases or sales) typically represent a repositioning within an account rather than fresh cash in or out. The specific mechanism matters less than what's left standing when the dust settles: energy.
Devon Energy is a Permian Basin and Eagle Ford operator. Coterra Energy runs Marcellus shale gas. Both are Oklahoma-adjacent stories in the sense that Hern's district covers Tulsa and the surrounding area, where oil and gas are the economy. The industries he kept are the industries his constituents work in. Make of that what you make of it.
The Ways and Means Lens
Hern sits on the House Committee on Ways and Means, with subcommittee assignments in Health and Tax. That's the relevant filter for asking whether any of his trading carries a committee-level angle.
The trades that warrant attention on that front come from earlier filings, not the last 90 days. In June and July 2024, Hern bought UnitedHealth Group (UNH) and Chubb (CB) in the ,000 to 5,000 range each. The UNH purchase logged a 30-day alpha of 12.8 percentage points above the S&P 500. The CB purchase logged 13.3 points. Both UNH and CB sit inside Ways and Means' actual jurisdiction: healthcare and insurance. Those two trades are the ones flagged as committee overlap in his record.
He later sold UNH in December 2025 for a $250,000 to $500,000 exit, which itself logged a positive 2.0-point 30-day alpha. The healthcare committee overlap runs through all three of those UNH and CB transactions.
The recent 90-day sell-off, by contrast, cuts across sectors that sit outside Ways and Means' lane entirely: semiconductors (Texas Instruments), logistics real estate (Prologis), financial services (Goldman Sachs, T. Rowe Price, Invesco), and consumer health (Kenvue, Becton Dickinson). Those are floor votes and broader portfolio decisions, not committee-level plays. The distinction matters. Hern's committee doesn't oversee semiconductor export controls or REIT tax treatment in any direct way. A sale of Texas Instruments is just a sale of Texas Instruments.
The Overall Alpha Record, Stated Honestly
Across 73 scored trades in Blind Trust's database, Hern has 31 positive-alpha outcomes and 42 negative ones. Mean 30-day alpha: negative 1.0 percent. The wins exist. They don't dominate.
The worst entry in the record: a Progress Software (PRGS) sale on March 16, 2026, in the $50,000 to 00,000 range, which logged negative 20.3 points of alpha over the following 30 days. Selling and then watching the stock recover by 20 points relative to the market is the kind of outcome that makes a trading record look human rather than algorithmic. Two separate sales of BNP Paribas ADRs on October 9, 2025 (one in the ,000,000 to $5,000,000 range, one in the $250,000 to $500,000 range) each logged negative 14.1-point alpha.
31 of 73. That's the record. The receipts are public.
The Votes on the Floor This Month
On May 20, Hern voted yes on the American Access to Banking Act and the Community Bank Deposit Access Act. Both passed. Neither sits in Ways and Means' actual jurisdiction: bank deposit regulation belongs to Financial Services. Hern voted on both as a rank-and-file floor member, not as an oversight committee member. His Goldman Sachs sale had cleared on April 29, three weeks earlier.
The vote-trade overlap file for Hern in this period is empty. There are no flagged coincidences between specific vote dates and specific trade dates in the 90-day window. That's worth noting because the absence is as much a data point as the presence would be.
What the floor votes do show is a member who voted yes on banking-access legislation while holding no financial sector positions anymore. The Goldman Sachs position was gone. So was Invesco. So was T. Rowe Price. By the time those bills hit the floor, Hern's financial sector exposure in the disclosed record had already been cleared.
Oklahoma Senate Race, Portfolio Edition
Hern is running for a seat that would give him significantly more institutional power than he has in the House. Senate Finance Committee assignments are different animals than Ways and Means subcommittee slots. More jurisdiction, longer tenure, more leverage over the kind of tax and healthcare legislation that moves sectors.
His current portfolio, as reflected in the 90-day trading window, is moving toward simplicity. Thirteen positions sold. Energy kept. The outgoing trades span a remarkable range of sectors for someone who sits on the tax and health subcommittees of Ways and Means, not because any of those sectors are in his committee lane, but because the breadth of the exits is the notable feature.
Members are required to disclose. They are not required to divest, recuse, abstain, or explain the sequencing. The gap between what's required and what might be expected has been sitting in the statute since the STOCK Act passed in 2012. It remains there today.
Hern's full 90-day trading record is available at Blind Trust's Kevin Hern disclosure page. The committee overlap trades, the alpha record, and the full vote history are all in the same place.
The receipts are public. Make of them what you make of them.